| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Genetics, Vol. 176, 1491-1499, July 2007, Copyright © 2007
doi:10.1534/genetics.107.071571
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1,2
,2

,3
* Howard Hughes Medical Institute, Harvard-Partners Center for Genetics and Genomics, Brigham & Women's Hospital, Boston, Massachusetts 02115,
Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115 and
Institute of Biomedical Research, University of Birmingham, Edgbaston B15 2TT, United Kingdom
3 Corresponding author: New Research Building, Room 168, 77 Avenue Louis Pasteur, Boston, MA 02115.
E-mail: mkuroda{at}genetics.med.harvard.edu
| ABSTRACT |
|---|
|
|
|---|
In Drosophila, X-chromosome dosage compensation is mediated by a histone-modifying complex called the male-specific-lethal (MSL) complex (LUCCHESI 1998; MELLER and KURODA 2002; GILFILLAN et al. 2004). The MSL complex binds specifically to genes along the male X chromosome, resulting in an approximately twofold increase in the transcription of X-linked genes in males (X) relative to females (XX), thereby compensating for the difference in X-chromosome number between the sexes. The MSL complex contains at least five proteins (MSL1, MSL2, MSL3, MLE, and MOF) and two noncoding RNAs (roX1 and roX2). MOF is a histone H4 lysine 16 (H4K16) acetyltransferase that catalyzes enriched H4K16 acetylation on the male X chromosome. This histone modification facilitates transcription, perhaps by specifically disrupting charge-based internucleosomal interactions between histone H4 and histone H2A, thus partially decondensing chromatin structure (SHOGREN-KNAAK et al. 2006).
The biochemical roles of the two noncoding RNAs in the MSL complex, roX1 and roX2, are largely unknown. Without the roX RNAs, MSL targeting to the X chromosome is very poor (MELLER and RATTNER 2002). The RNAs are functionally redundant although they differ in both sequence and size. The genes that encode the two roX RNAs are positioned at distinct locations, near the tip (roX1) and the middle (roX2) of the euchromatic portion of the X chromosome (Figure 1A). Our previous studies suggest that nascent roX RNA transcripts serve as local nucleation sites for assembly of the complex (PARK et al. 2002; BAI et al. 2004). This can be seen when roX transgenes are inserted at ectopic positions on the autosomes, particularly when the endogenous X chromosome lacks both roX genes. Therefore, the location of roX genes on the X chromosome could facilitate initial binding to that chromosome. Whether roX genes contribute regionally to MSL targeting on the X chromosome is not evident, however, from the final colocalization of roX RNAs and MSL proteins along the length of the chromosome in wild type or roX1 or roX2 single mutant males.
|
Genetic ablation of NURF301 and ISWI confirms that NURF is essential for viability (DEURING et al. 2000; BADENHORST et al. 2002). Moreover, NURF-mediated nucleosome sliding appears to be involved in both transcriptional activation and repression. In Nurf301 and Iswi mutants the activation of heat-shock genes, the homeotic genes Ubx and engrailed, and ecdysone responsive genes is blocked (DEURING et al. 2000; BADENHORST et al. 2002, 2005). Conversely, loss of NURF leads to activation of the JAK/STAT pathway, resulting in melanotic tumors caused by overproliferation of larval blood cells (BADENHORST et al. 2002). Consistent with NURF functioning both as an activator or repressor of transcription, whole genome expression profiling indicates that large numbers of genes are both up- and downregulated in Nurf301 mutants although the direct target loci remain unknown (BADENHORST et al. 2005).
The activities of the MSL and NURF complexes intersect on the male X chromosome, revealing a potentially complementary or antagonistic relationship. The male polytene X chromosome in either Nurf301 or Iswi mutants is severely distorted (DEURING et al. 2000; BADENHORST et al. 2002). In the absence of NURF, the male X chromosome becomes disorganized and highly decondensed, appearing very wide at the expense of length. MSL staining of this aberrant polytene X chromosome reveals strong MSL localization without the typical banded pattern seen on wild-type X chromosomes. Interestingly, the aberrant male-specific X morphology can be suppressed by disrupting dosage compensation (in mle mutants) and, conversely, can be induced in females by forced expression of the MSL complex (CORONA et al. 2002). One explanation for this phenotype is that NURF is essential for chromatin organization on all chromosomes, but that as the maternal supply of NURF is dissipated in homozygous Nurf301 or Iswi mutants, the male X chromosome becomes the first to lose its defined morphology due to antagonism between the MSL and NURF complexes. Consistent with this idea, biochemical studies demonstrate that acetylation of histone H4K16 reduces interaction of ISWI with nucleosomes, suggesting that MSL-mediated histone modification may directly disrupt the chromosomal organization function of NURF (CLAPIER et al. 2002; CORONA et al. 2002). Conversely, ISWI has been proposed to block the positive effects of H4K16ac on the X chromosome in an alternative model for dosage compensation (BHADRA et al. 2005).
In this study, we utilize the Nurf301 mutant phenotype to assay the importance of roX gene location on the X chromosome. We find that the aberrant morphology of the male X chromosome in Nurf301 mutants can be regionally suppressed by deletion of either roX1 or roX2, providing strong evidence that roX genes function over very long distances along the X chromosome. In addition to interacting functions at the level of chromosome morphology, we also find that NURF and MSL proteins have opposing effects on roX gene transcription, with NURF repressing roX transcription in females. Together, these results demonstrate the importance of a local balance between factors that promote and antagonize chromatin compaction.
| MATERIALS AND METHODS |
|---|
|
|
|---|
4.3] X chromosomes. yw roX1+roX2–; Nurf3013 male larvae were generated by a brother-sister cross of yw roX1+roX2–; Nurf3013/Tb flies. roX1–roX2+; Nurf3013 male larvae were generated using yw roX1ex6; Nurf3013/Tb flies.
Polytene chromosome immunostaining:
Polytene chromosomes were prepared and immunostained using anti-MSL1 or anti-MSL2 antibodies as previously described (KELLEY et al. 1999). The Nurf301 mutant male X-chromosome allelic series was generated using larvae hemizygous for, respectively, Nurf3012, Nurf3013, Nurf3014, Nurf3015, Nurf30110, and Nurf30112. Hemizygotes were generated by crossing the respective Nurf301 allele to Df(3L)3643. All strains were balanced using TM6B, Tb, allowing mutant larvae to be selected as non-Tb.
Quantitative real-time RT–PCR:
DNaseI-treated total RNA was subjected to first-strand cDNA synthesis using SuperScriptII reverse transcriptase (Invitrogen) and primed by oligo dT. Real-time PCR was performed using the ABI PRISM 7000 sequence detection system (Applied Biosystems). The Pka gene was used as the internal reference for normalizing variance in the quality of RNA and the amount of input cDNA. PCR amplification was performed as previously described (BAI et al. 2004). Relative quantification of tested transcriptions was determined by the comparative CT method based on the manufacturer's instruction (Applied Biosystems). A standard curve for each set of primers was constructed using a serial dilution of cDNA to verify equal amplification efficiency. The primers used for real-time PCR are Pka: forward 5'-TTCTCGGAGCCGCACTCGCGCTTCTAC3' and reverse 5'-CAATCA GCAGATTCTCCGGCT-3'; Reporter: forward 5'-AGCACGACTTCTTCAAGTCCG-3' and reverse 5'-GTGTCGCCCTCGA ACTTCAC-3'; roX1: forward 5'-ATGCGAGCGAGACAATGATACT-3' and reverse 5'-GACTTGCAGTCCGCCCTATG-3'; roX2: forward 5'-AGCTCGGATGGCCATCGAAA-3' and reverse 5'-CGTTACTCTTGCTTGATTTTGCTTCG-3'; glutamine synthetase 2 (Gs2): forward 5'-TGCAGGAGAACATCGTTCAG-3' and reverse 5'-TCCATCGTAGTTCCAAACGG-3'; phosphogluconate dehydrogenase (Pgd): forward 5'GAACACACGAAACATGAGCG-3' and reverse 5'-CTCGTCCATGTTGAGTATCAGG-3'; and Zwischenferment (Zw): forward 5'-TGACCGTCGATAGCATCAAG-3' and reverse 5'-CCAGAACTCCTCGTACTTCTTC-3'.
Chromatin immunoprecipitation:
Chromatin immunoprecipitation (ChIP) was performed as described in BADENHORST et al. (2005). As ChIP-grade antibodies against the NURF-specific subunit NURF301 are unavailable, antibodies against the catalytic subunit ISWI were used. ISWI ChIP signals that are due to NURF were resolved by comparing ChIP profiles of wild-type and Nurf3012 mutant tissues (that lack NURF). Third instar larval salivary glands were used in ChIP. For most ChIP experiments, mixed samples of both male and female larvae were used. For sex-specific ChIP experiments, larvae were sexed by observing the gonad under a stereo microscope and sorted into female-only and male-only populations. All subsequent procedures were identical. Salivary glands were dissected on ice, pooled, and fixed in batches of 25 pairs of glands. After fixation, formaldehyde was removed by extensive washing with ice-cold PBS and glands stored as pellets at –70° until further use. For each ChIP experiment 75 pairs of wild type and 150 pairs of Nurf3012 mutant salivary glands were used. Immune complexes were precipitated using protein A-conjugated magnetic beads (Dynal). Target DNA abundance in ChIP eluates was assayed by quantitative PCR with addition of 0.2 µCi [
-32P]-deoxyadenosine 5'-triphosphate (Perkin-Elmer, specific activity 6000 Ci/mmol) as a tracer before the amplification step. Quantification of PCR products was conducted using a PhosphorImager screen. The ratio of ChIP sample to input sample was determined after titration of samples, and variation of PCR cycle number was conducted to ensure that all PCR products quantified are in the linear range. Typically, 0.5% of the final input sample and 3% of the final immunoprecipitation (IP) sample are used for quantitation. The final input sample is 5% of the total material added to the IP. Data presented are the mean of three separate determinations. Variation between ChIP analyses was <10%. Primer pairs for PCR were roX1 set 1: 5'-ACATGGGCGTAGTTTCATATACG-3' and 5'-TACATCTTGCCAGAGATTTCG-3'; roX1 set 2: 5'-ACGCGTACGCATACCTCTATC-3' and 5'-GAGCGGAGCGGTATTCGTGAG-3'; roX2 set 1: 5'ATATGAGCCACGTCATGGGT-3' and 5'-GGGAACTGCATGAATGCGAA-3'; roX2 set 2: 5'-AGCTCGGATGGCCATCGAAA-3' and 5'-CGTTACTCTTGCTTGATTTTGCTTCG-3'; and roX2 set 3: 5'-ACTAGTGAAATGTTATACGAAAC-3' and 5'-TGTAATTTAAGTGTCAGTTC-3'.
| RESULTS |
|---|
|
|
|---|
roX mutations suppress the Nurf301 mutant phenotype in cis on the male X chromosome:
The local puffing on the X chromosome in Nurf301 mutants prompted us to examine whether roX genes could modulate the Nurf301 phenotype. Previous studies showed that disrupting MSL function by a mutation in mle could suppress the puffed X morphology caused by loss of NURF function (CORONA et al. 2002). Although deletion of a single roX gene normally has no effect on the distribution or function of the MSL complex, we found that mutation of either roX1 or roX2 could regionally inhibit the disrupted X morphology in Nurf301 mutants (Figure 2, A and B). There was a striking inverse correlation between the regional puffing retained on the X chromosome and the site of roX mutation. As shown in Figure 2A, when roX2 was missing on the male X chromosome, MSL complexes were found to accumulate around the roX1+ locus and the surrounding region displayed a very puffed morphology with a dramatic loss of the normal banding pattern, while the rest of the X chromosome displayed more normal levels of MSL staining. In contrast, if roX1 was missing, the bulk of MSL complexes were restricted on the proximal half of the X chromosome surrounding the roX2+ locus, resulting in chromosome puffing only in that region (Figure 2B). These phenotypes were consistent from nucleus to nucleus and were present in multiple individual larvae. These data strongly support the idea that the MSL complex opposes compaction mediated by NURF to regulate male X-chromosome morphology. More importantly, these results suggest that roX genes, which are proposed to be MSL assembly and spreading initiation sites (PARK et al. 2002; OH et al. 2003), can regulate the X chromosome in cis.
|
|
To investigate whether NURF represses roX transcription we first analyzed expression of heterologous roX reporter constructs in Nurf mutants. In these experiments, expression of a GFP reporter is driven by the endogenous roX promoter, to which its cognate MSL binding site is either added or omitted, 3' to the GFP reporter (Figure 4A). These regulatory sites, previously shown to function as MSL-dependent enhancers of roX transcription, are male-specific DNase hypersensitive sites (DHS). The constructs analyzed were ProX1 vs. ProX1-DHS and ProX2 vs. ProX2-DHS (BAI et al. 2004). Previous studies have shown that the roX1 reporter is repressed in females through the same region that binds the MSL complex, forms the DHS, and activates roX1 in males. In contrast, repression of the roX2 reporter is independent of its MSL binding site (DHS). Both the roX1 and roX2 reporter systems were tested in Nurf301 mutant larvae by real-time RT–PCR. As shown in Figure 4B, in Nurf301 females the ProX1-DHS reporter was derepressed, reaching an expression level comparable to that of the ProX1 reporter. In addition, the expression of both ProX2 and ProX2-DHS were increased in Nurf mutant females (Figure 4C), demonstrating that both reporters are repressed by NURF in wild-type females. Similar effects were observed in Iswi mutant females (data not shown). The expression of roX reporters in male Nurf301 and Iswi mutant larvae was unchanged (data not shown). Thus, NURF clearly functions to repress expression from roX gene reporters in females. While these data do not explain the local effects of roX genes on puffing of the X chromosome in males, they provide a second example of the opposing functions of NURF and MSL complexes.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
NURF controls roX transcription:
Previous analyses indicated that MSL proteins are required for transcription of roX genes (BAI et al. 2004). In the case of roX1, the MSL complex binds to the DHS and counteracts the activity of a constitutive repressor, establishing the male-specific pattern of roX1 transcription. Our analysis of endogenous roX transcript levels and heterologous roX reporter constructs indicate that NURF mediates this repression and that, for roX1, NURF acts through the DHS. This is confirmed by ChIP analysis that shows NURF is recruited to the roX1 DHS, demonstrating that regulation is direct.
The requirement for NURF in roX repression was detected in females that do not ordinarily express roX genes. In the absence of NURF, endogenous levels of both roX1 and roX2 are increased in females. In males, steady-state transcript levels are either unaffected (roX1) or increased approximately twofold (roX2). It is clear from the extreme decondensation of the NURF mutant male X chromosome and its suppression by roX and MSL complex mutants that the male X chromosome is very sensitive to the loss of the NURF complex. One model that may reconcile the apparent contradiction between lack of roX gene derepression in Nurf mutant males and the extreme male X chromosome phenotype is as follows: NURF may affect key initial levels of roX RNAs at embryonic stages when MSL complex binding is first initiated. The effect of improperly regulated complex assembly during initial stages could be progressively amplified during development resulting in a chromosome morphology defect at a time when roX gene expression is no longer regulated by NURF in males. Alternatively, antagonism at the level of roX transcription and at the level of chromatin morphology may be functionally independent events.
Mechanism of NURF and MSL antagonism:
A principal activity of NURF is ATP-dependent nucleosome sliding in cis on DNA without displacement (HAMICHE et al. 1999). It is not difficult to envisage how nucleosome sliding can be used to expose or block binding sites for transcription factors and thereby control transcription. Indeed there is much evidence from studies of the orthologous yeast Isw2 remodeling complex that nucleosome sliding can be used to repress transcription. Isw2 is needed to repress early meiotic genes and targets of the Tup1-Ssn6 complex (GOLDMARK et al. 2000; KENT et al. 2001; RUIZ et al. 2003; ZHANG and REESE 2004). However, in these cases, repression is mediated through 5' regulatory elements at the level of transcription initiation. As we have seen above, NURF represses roX1 through a binding site present in the coding region,
1 kb 3' of the transcription initiation site.
The location of NURF binding within the roX1 gene becomes more pertinent when the known distribution of the MSL complex is considered. Recent whole genome profiling of MSL complex distribution on X-chromosome targets indicates that the complex shows a strong preference for the 3' ends of gene targets (ALEKSEYENKO et al. 2006; GILFILLAN et al. 2006). This correlates with a previous, more restricted, analysis showing that acetylation of H4K16, the epigenetic mark established by the MSL complex, follows a similar distribution (SMITH et al. 2001). One implication of this distribution is that the MSL complex may regulate transcription of targets (including roX genes) not at the level of transcription initiation, but by improving elongation. It is tempting to speculate that NURF may also control elongation, as suggested by studies of the yeast ISW1 complex (MORILLON et al. 2003).
Model for regional action of roX genes on the X chromosome:
Here we find that the aberrant morphology of the male X chromosome in Nurf301 mutants is regionally suppressed by deletion of either roX1 or roX2, providing strong visual evidence that roX genes can function in cis over long distances (>1 Mb). We believe that our results are consistent with a model in which nascent roX RNAs normally assemble and nucleate "spreading" of MSL complexes along the X chromosome. The term "spreading" has been controversial as it is subject to a myriad of interpretations. What we mean by spreading is that following assembly, the MSL complex is much more likely to act regionally, in cis, than to be unconstrained. We previously proposed that in addition to roX genes, specific MSL interaction occurs at "high affinity sites" (also termed "chromatin entry sites") whose identifying characteristics are yet to be defined (LYMAN et al. 1997; KELLEY et al. 1999; DEMAKOVA et al. 2003; OH et al. 2004; DAHLSVEEN et al. 2006). "Spreading" from roX genes and high affinity sites to the full MSL binding pattern could occur by scanning along the chromosome in a linear mode, but it could also occur solely by local release and recapture of the complex by regions in close physical proximity. Movement from one DNA molecule to another clearly can occur when roX genes or various segments of X are moved to autosomes (MELLER et al. 1997; KELLEY et al. 1999; FAGEGALTIER and BAKER 2004; OH et al. 2004; DAHLSVEEN et al. 2006).
High affinity sites and roX genes might normally function together to constrain the MSL complex largely to the X chromosome. An "affinities" model developed in a series of reports (DEMAKOVA et al. 2003; FAGEGALTIER and BAKER 2004; DAHLSVEEN et al. 2006) posits that there is a continuum of affinity sites for MSL complexes, ranging from high to low, and that only when high sites are locally concentrated can low affinity sites be recognized. In our opinion, this clearly falls under the general premise of the spreading model. In both cases, MSL targeting is a multistep process in which many binding sites are not recognized independently, in the absence of influence of neighboring sites in cis. While the image of X-chromosome morphology regionally controlled by the presence or absence of a roX gene is, to us, strong evidence for function of roX genes over long distances in cis, a more mechanistic view of MSL targeting clearly awaits additional data on the molecular nature of MSL–chromatin interactions.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
2 These authors contributed equally to this work. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
ALEKSEYENKO, A. A., E. LARSCHAN, W. R. LAI, P. J. PARK and M. I. KURODA, 2006 High-resolution ChIP-chip analysis reveals that the Drosophila MSL complex selectively identifies active genes on the male X chromosome. Genes Dev. 20: 848–857.
BADENHORST, P., M. VOAS, I. REBAY and C. WU, 2002 Biological functions of the ISWI chromatin remodeling complex NURF. Genes Dev. 16: 3186–3198.
BADENHORST, P., H. XIAO, L. CHERBAS, S. Y. KWON, M. VOAS et al., 2005 The Drosophila nucleosome remodeling factor NURF is required for Ecdysteroid signaling and metamorphosis. Genes Dev. 19: 2540–2545.
BAI, X., A. A. ALEKSEYENKO and M. I. KURODA, 2004 Sequence-specific targeting of MSL complex regulates transcription of the roX RNA genes. EMBO J. 23: 2853–2861.[CrossRef][Medline]
BARAK, O., M. A. LAZZARO, W. S. LANE, D. W. SPEICHER, D. J. PICKETTS et al., 2003 Isolation of human NURF: a regulator of Engrailed gene expression. EMBO J. 22: 6089–6100.[CrossRef][Medline]
BHADRA, M. P., U. BHADRA, J. KUNDU and J. A. BIRCHLER, 2005 Gene expression analysis of the function of the male-specific lethal complex in Drosophila. Genetics 169: 2061–2074.
CLAPIER, C. R., K. P. NIGHTINGALE and P. B. BECKER, 2002 A critical epitope for substrate recognition by the nucleosome remodeling ATPase ISWI. Nucleic Acids Res. 30: 649–655.
CORONA, D. F., C. R. CLAPIER, P. B. BECKER and J. W. TAMKUN, 2002 Modulation of ISWI function by site-specific histone acetylation. EMBO Rep. 3: 242–247.[CrossRef][Medline]
DAHLSVEEN, I. K., G. D. GILFILLAN, V. I. SHELEST, R. LAMM and P. B. BECKER, 2006 Targeting determinants of dosage compensation in Drosophila. PLoS Genet. 2: e5.[CrossRef][Medline]
DEMAKOVA, O. V., I. V. KOTLIKOVA, P. R. GORDADZE, A. A. ALEKSEYENKO, M. I. KURODA et al., 2003 The MSL complex levels are critical for its correct targeting to the chromosomes in Drosophila melanogaster. Chromosoma 112: 103–115.[CrossRef][Medline]
DEURING, R., L. FANTI, J. A. ARMSTRONG, M. SARTE, O. PAPOULAS et al., 2000 The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo. Mol. Cell 5: 355–365.[CrossRef][Medline]
FAGEGALTIER, D., and B. S. BAKER, 2004 X chromosome sites autonomously recruit the dosage compensation complex in Drosophila males. PLoS Biol. 2: e341.[CrossRef][Medline]
GILFILLAN, G. D., I. K. DAHLSVEEN and P. B. BECKER, 2004 Lifting a chromosome: dosage compensation in Drosophila melanogaster. FEBS Lett. 567: 8–14.[CrossRef][Medline]
GILFILLAN, G. D., T. STRAUB, E. DE WIT, F. GREIL, R. LAMM et al., 2006 Chromosome-wide gene-specific targeting of the Drosophila dosage compensation complex. Genes Dev. 20: 858–870.
GOLDMARK, J. P., T. G. FAZZIO, P. W. ESTEP, G. M. CHURCH and T. TSUKIYAMA, 2000 The Isw2 chromatin remodeling complex represses early meiotic genes upon recruitment by Ume6p. Cell 103: 423–433.[CrossRef][Medline]
HAMICHE, A., R. SANDALTZOPOULOS, D. A. GDULA and C. WU, 1999 ATP-dependent histone octamer sliding mediated by the chromatin remodeling complex NURF. Cell 97: 833–842.[CrossRef][Medline]
ITO, T., M. BULGER, M. J. PAZIN, R. KOBAYASHI and J. T. KADONAGA, 1997 ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell 90: 145–155.[CrossRef][Medline]
KELLEY, R. L., V. H. MELLER, P. R. GORDADZE, G. ROMAN, R. L. DAVIS et al., 1999 Epigenetic spreading of the Drosophila dosage compensation complex from roX RNA genes into flanking chromatin. Cell 98: 513–522.[CrossRef][Medline]
KENT, N. A., N. KARABETSOU, P. K. POLITIS and J. MELLOR, 2001 In vivo chromatin remodeling by yeast ISWI homologs Isw1p and Isw2p. Genes Dev. 15: 619–626.
LUCCHESI, J. C., 1998 Dosage compensation in flies and worms: the ups and downs of X-chromosome regulation. Curr. Opin. Genet. Dev. 8: 179–184.[CrossRef][Medline]
LYMAN, L. M., K. COPPS, L. RASTELLI, R. L. KELLEY and M. I. KURODA, 1997 Drosophila male-specific lethal-2 protein: structure/function analysis and dependence on MSL-1 for chromosome association. Genetics 147: 1743–1753.[Abstract]
MELLER, V. H., and M. I. KURODA, 2002 Sex and the single chromosome. Adv. Genet. 46: 1–24.[Medline]
MELLER, V. H., and B. P. RATTNER, 2002 The roX genes encode redundant male-specific lethal transcripts required for targeting of the MSL complex. EMBO J. 21: 1084–1091.[CrossRef][Medline]
MELLER, V. H., K. H. WU, G. ROMAN, M. I. KURODA and R. L. DAVIS, 1997 roX1 RNA paints the X chromosome of male Drosophila and is regulated by the dosage compensation system. Cell 88: 445–457.[CrossRef][Medline]
MORILLON, A., N. KARABETSOU, J. O'SULLIVAN, N. KENT, N. PROUDFOOT et al., 2003 Isw1 chromatin remodeling ATPase coordinates transcription elongation and termination by RNA polymerase II. Cell 115: 425–435.[CrossRef][Medline]
OH, H., Y. PARK and M. I. KURODA, 2003 Local spreading of MSL complexes from roX genes on the Drosophila X chromosome. Genes Dev. 17: 1334–1339.
OH, H., J. R. BONE and M. I. KURODA, 2004 Multiple classes of MSL binding sites target dosage compensation to the X chromosome of Drosophila. Curr. Biol. 14: 481–487.[CrossRef][Medline]
PARK, Y., R. L. KELLEY, H. OH, M. I. KURODA and V. H. MELLER, 2002 Extent of chromatin spreading determined by roX RNA recruitment of MSL proteins. Science 298: 1620–1623.
RUIZ, C., V. ESCRIBANO, E. MORGADO, M. MOLINA and M. J. MAZON, 2003 Cell-type-dependent repression of yeast a-specific genes requires Itc1p, a subunit of the Isw2p-Itc1p chromatin remodelling complex. Microbiology 149: 341–351.
SHOGREN-KNAAK, M., H. ISHII, J. M. SUN, M. J. PAZIN, J. R. DAVIE et al., 2006 Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311: 844–847.
SMITH, E. R., C. D. ALLIS and J. C. LUCCHESI, 2001 Linking global histone acetylation to the transcription enhancement of X-chromosomal genes in Drosophila males. J. Biol. Chem. 276: 31483–31486.
VARGA-WEISZ, P. D., M. WILM, E. BONTE, K. DUMAS, M. MANN et al., 1997 Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature 388: 598–602.[CrossRef][Medline]
XIAO, H., R. SANDALTZOPOULOS, H. M. WANG, A. HAMICHE, R. RANALLO et al., 2001 Dual functions of largest NURF subunit NURF301 in nucleosome sliding and transcription factor interactions. Mol. Cell 8: 531–543.[CrossRef][Medline]
ZHANG, Z., and J. C. REESE, 2004 Ssn6-Tup1 requires the ISW2 complex to position nucleosomes in Saccharomyces cerevisiae. EMBO J. 23: 2246–2257.[CrossRef][Medline]
Communicating editor: B. J. MEYERThis article has been cited by other articles:
![]() |
F. Li, A. H. Schiemann, and M. J. Scott Incorporation of the Noncoding roX RNAs Alters the Chromatin-Binding Specificity of the Drosophila MSL1/MSL2 Complex Mol. Cell. Biol., February 15, 2008; 28(4): 1252 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Levine, A. K. Holloway, U. Arshad, and D. J. Begun Pervasive and Largely Lineage-Specific Adaptive Protein Evolution in the Dosage Compensation Complex of Drosophila melanogaster Genetics, November 1, 2007; 177(3): 1959 - 1962. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |